A1RG34:BVMF
Argenx Se Bdr
187,38 BRL
arrow_upward
+1,99%(+3,65) 1D
6-окт., 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Open
187,38 BRL
High
187,38 BRL
Low
187,38 BRL
Mkt. cap
58,45 млд
Avg. vol.
57,00
Volume
0,00
52-wk high
213,15 BRL
52-wk low
143,22 BRL
Shares outstanding
62,56 млн
No. of employees
2 миң
Open
187,38 BRL
High
187,38 BRL
Low
187,38 BRL
Mkt. cap
58,45 млд
Avg. vol.
57,00
Volume
0,00
52-wk high
213,15 BRL
52-wk low
143,22 BRL
Shares outstanding
62,56 млн
No. of employees
2 миң
News stories
From web sources and news partners
Investing.com UK
·
9 саат мурун
Halozyme expands argenx collaboration with two new targets By Investing.com
Yahoo Finance
·
10 саат мурун
Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx to Support the Development of Subcutaneous Formulations for Two Additional Exclusive Targets Using its ENHANZE® Technology
AD HOC NEWS
·
13 саат мурун
argenx stock: New VYVGART data span myasthenia gravis and CIDP
The Motley Fool
·
1 күн мурун
10 Wall Street Analysts Think Argenx Stock Is Headed to At Least $1,200 -- Is the Stock a Buy Now?
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr